Source coverage

See what we cover—
and where it stops.

Compare the public source records behind PeptideScanner profiles and updates, inspect current coverage and known gaps, and open the cited sources.

This page shows
Who published each cited record, how PeptideScanner uses it, and known gaps in the current collection.
It does not establish
Inclusion is not a source rating, endorsement, or claim of comprehensive monitoring.
Currently covered

Selected ClinicalTrials.gov studies plus 10,648 public registry-history versions, 1447 retained PubMed metadata records, 27 exact selected NCT-to-PMID links, 1,094 dated Drugs@FDA submissions with 1,317 official document links, 22 exact-application FDA enforcement reports, 98 Federal Register documents attributed to FDA and HHS, 244 DailyMed SPL versions across 22 reviewed label families, selected FDA and Justice Department records, and 97 bounded Crossref publication checks.

How records appear

Narrow source lanes publish only bounded, validated metadata. Drugs@FDA history uses exact relational submission, action-type, and document keys while excluding missing or sentinel dates and unresolved foreign keys; it links official documents without ingesting their bodies. The trial-publication graph admits only structured NCT and PMID declarations and preserves whether PubMed, ClinicalTrials.gov, or both supplied each edge. ClinicalTrials.gov history reports source-submitted dates and changed-module labels without copying or interpreting study text; DailyMed history retains exact historical ZIP byte counts and SHA-256 receipts; Federal Register records require exact reviewed peptide-name matches and official GovInfo PDFs.

Known gaps

Coverage is not exhaustive—even within a listed peptide. The graph connects only endpoints already present in the two reviewed public authorities and does not infer missing publication links. ClinicalTrials.gov history covers only the 712 already reviewed trials and excludes source-declared review-not-passed or unposted entries; DailyMed reports version availability but not label-section changes, while PubMed and Federal Register remain bounded selections. Non-U.S. regulators, company announcements, and secondary reporting are not systematically covered.

Crossref Research Integrity v1

A separate metadata check for synthesis publications

PeptideScanner checked 97 DOI-backed PubMed sources selected for supervised synthesis and retained 6 Crossref-attributed publication update notices. This is a dated, bounded review—not continuous monitoring and not complete coverage of the public bibliography.

Inspect checks and limitations

Public citations

2747 cited records

Showing 2747 cited records

Suzhou Industrial Park Market Supervision Bureau

Official source · 1 cited record

Suzhou Municipal Government

Official source · 1 cited record

U.S. Food and Drug Administration

Official source · 21 cited records

ClinicalTrials.gov

Official source · 771 cited records

PubMed

Official source · 1447 cited records

Drugs@FDA via openFDA

Official source · 110 cited records

Federal Register via GovInfo

Official source · 98 cited records

FDA enforcement reports via openFDA

Official source · 22 cited records

DailyMed · U.S. National Library of Medicine

Official source · 270 cited records

U.S. Department of Justice

Official source · 1 cited record

FDA Global Substance Registration System

Official source · 5 cited records

How we use sources

Official and primary records

Regulators, trial registries, government notices, and official label repositories. These sources support only what that body recorded or did.

Company or institutional statements

Claims remain explicitly attributed and are never presented as independent conclusions.

Secondary reporting

Useful for discovery and context. PeptideScanner prefers an underlying primary record whenever one is available.